Researchers Develop Implantable Glucose Monitoring Device for Diabetics

Researchers at the University of California San Diego and GlySens Inc. are developing an implantable wireless sensor to continuously monitor blood sugar in diabetes patients, Reuters reports.

Read more »

Echo Therapeutics Rated Strong Spec Buy by Life Tech Capital

The significant differences between Echo Therapeutics’ Symphony system and the competition is the needle-free transdermal biosensor, clinical trials in the hospital setting and biosensor life.

Read more »

[OneMedForum] OrSense: Non-Invasive Blood Monitoring Solutions

Israel-based OrSense is attempting to increase patient compliance with a non-invasive continuous glucose monitor based on optical technology.

Read more »

Echo Therapeutics: Positive Developments for Needle-Free Monitoring System

On 11/19/09, the Company announced positive results in a pilot clinical study which included Prelude skin preparation and the placement of 10 Symphony tCGM biosensors on subjects with Type 1 or Type 2 Diabetes.

Read more »

[Company Profile] Echo Therapeutics

Echo Therapeutics of Franklin, Mass., has developed the Symphony tCGM System, a needle-free, wireless system that allows patients to painlessly and accurately monitor their blood glucose levels around the clock.

Read more »

Medtronic Acquires Diabetes Tech from PreciSense

Medtronic announced at its annual investor meeting that it has acquired substantially all glucose monitoring technology from Danish company PreciSense.

Read more »